ArriVent BioPharma Inc — Dividend History & Yield (NASDAQ:AVBP) | MetaTrader

Open full chart

Financials

Overview 성명 Statistics Dividends

Quarterly Annual

Dividends per share — — Dividend yield % — — Payout ratio % — —

뉴스

ArriVent, Cantor Fitzgerald ’비중확대’ 등급 재확인

ArriVent stock rating reiterated as Overweight by Cantor Fitzgerald

오펜하이머, ArriVent BioPharma에 ’Outperform’ 등급 재확인

Oppenheimer reiterates Outperform rating on ArriVent BioPharma stock

ArriVent BioPharma (AVBP): Its Leading Asset, Furmonertinib, Supports A Cautious Buy

ArriVent BioPharma: A De-Risked Binary With Near-Term Catalysts (NASDAQ:AVBP)

칸토어 피츠제럴드, 아리벤트 바이오파마에 ’비중확대’

Cantor Fitzgerald initiates ArriVent BioPharma stock with Overweight rating

ArriVent doses first patient in pivotal phase 3 trial for lung cancer drug

아리벤트 바이오파마, BTIG에서 ’매수’ 등급으로 투자 시작, 종양학 잠재력 주목

ArriVent BioPharma stock initiated with Buy rating at BTIG on oncology potential

아리벤트 바이오파마, Truist에서 ’매수’ 등급으로 시작, 폐암 치료제 관련